Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretreatment submucosal tramadol versus dexamethasone versus saline for postendodontic pain in mandibular molars with symptomatic irreversible pulpitis
TCTR20190529001Completed
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tramadol, dexamethasone and saline in irreversible pulpitis (3 arms), sponsored by none. Primary endpoint: Postendodontic pain control at 72 hours. Started Oct 2018; status: completed.
02
Drugs
tramadoldexamethasonesaline
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on TCTR20190529001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190529001.